Brolucizumab in HAWK/HARRIER: Outcomes, Efficacy, & Dosing Status – Everything You Need to Know!

Related

• 

  Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results

  Sam E. Mansour, MD, MSc,FACS, FRCS(C)

  Annual Meeting Talks

  2018

• 

  Factors Associated with Worsening Proliferative Diabetic Retinopathy

  Carl W. Baker, MD

  Updates from the Field

  2017

• 

  Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent

  Nancy M. Holekamp, MD

  J. Michael Jumper, MD

  Paul Chan

  Adrienne W. Scott, MD

  Webinars and Journal Clubs

  2017